Champlain Investment Partners Upped Position in John Bean Technologies Corpora (JBT) by $637,387; As Ignyta (RXDX) Stock Declined, Shareholder Armistice Capital Lowered Its Position

December 8, 2017 - By Adrian Erickson

Armistice Capital Llc decreased its stake in Ignyta Inc (RXDX) by 32.71% based on its latest 2017Q2 regulatory filing with the SEC. Armistice Capital Llc sold 486,000 shares as the company’s stock declined 28.13% while stock markets rallied. The institutional investor held 1.00M shares of the health care company at the end of 2017Q2, valued at $10.35M, down from 1.49M at the end of the previous reported quarter. Armistice Capital Llc who had been investing in Ignyta Inc for a number of months, seems to be less bullish one the $1.05B market cap company. The stock increased 1.94% or $0.3 during the last trading session, reaching $15.8. About 519,634 shares traded. Ignyta, Inc. (NASDAQ:RXDX) has risen 14.24% since December 8, 2016 and is uptrending. It has underperformed by 2.46% the S&P500.

Champlain Investment Partners Llc increased its stake in John Bean Technologies Corpora (JBT) by 1.48% based on its latest 2017Q2 regulatory filing with the SEC. Champlain Investment Partners Llc bought 6,571 shares as the company’s stock declined 1.59% while stock markets rallied. The institutional investor held 449,746 shares of the industrial machinery and components company at the end of 2017Q2, valued at $44.08 million, up from 443,175 at the end of the previous reported quarter. Champlain Investment Partners Llc who had been investing in John Bean Technologies Corpora for a number of months, seems to be bullish on the $3.64B market cap company. The stock increased 0.35% or $0.4 during the last trading session, reaching $115.15. About 144,230 shares traded. John Bean Technologies Corporation (NYSE:JBT) has risen 40.52% since December 8, 2016 and is uptrending. It has outperformed by 23.82% the S&P500.

Analysts await Ignyta, Inc. (NASDAQ:RXDX) to report earnings on March, 13. They expect $-0.45 EPS, up 32.84% or $0.22 from last year’s $-0.67 per share. After $-0.51 actual EPS reported by Ignyta, Inc. for the previous quarter, Wall Street now forecasts -11.76% EPS growth.

Investors sentiment increased to 2.96 in Q2 2017. Its up 1.63, from 1.33 in 2017Q1. It improved, as 8 investors sold RXDX shares while 16 reduced holdings. 37 funds opened positions while 34 raised stakes. 42.58 million shares or 67.92% more from 25.35 million shares in 2017Q1 were reported. Fmr Limited Liability Corp stated it has 0% in Ignyta, Inc. (NASDAQ:RXDX). 50,000 were reported by Moore Cap Ltd Partnership. Iguana Healthcare Mngmt Limited Com has invested 0.29% of its portfolio in Ignyta, Inc. (NASDAQ:RXDX). Thompson Davis And Incorporated has 250 shares. Citigroup has invested 0% in Ignyta, Inc. (NASDAQ:RXDX). State Street Corporation invested in 766,404 shares or 0% of the stock. Opus Point Partners Mgmt Lc stated it has 1.62% in Ignyta, Inc. (NASDAQ:RXDX). Bvf Il accumulated 700,000 shares. Legal & General Grp Inc Plc invested in 12,681 shares. Emerald Mutual Fund Advisers Tru has invested 0.52% in Ignyta, Inc. (NASDAQ:RXDX). Dimensional Fund Advsr Limited Partnership accumulated 0% or 55,915 shares. Point72 Asset Mngmt Limited Partnership, a Connecticut-based fund reported 277,900 shares. Pointstate Cap Limited Partnership holds 580,100 shares or 0.07% of its portfolio. California State Teachers Retirement invested in 88,511 shares or 0% of the stock. Cormorant Asset Mngmt Llc has invested 2.57% in Ignyta, Inc. (NASDAQ:RXDX).

Among 9 analysts covering Ignyta (NASDAQ:RXDX), 9 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Ignyta has $38 highest and $1500 lowest target. $23.88’s average target is 51.14% above currents $15.8 stock price. Ignyta had 17 analyst reports since August 12, 2015 according to SRatingsIntel. Cantor Fitzgerald initiated the shares of RXDX in report on Tuesday, November 10 with “Buy” rating. The stock of Ignyta, Inc. (NASDAQ:RXDX) earned “Overweight” rating by JP Morgan on Thursday, June 23. The firm has “Buy” rating given on Monday, October 26 by Canaccord Genuity. Cantor Fitzgerald maintained it with “Buy” rating and $1500 target in Sunday, June 4 report. The stock has “Buy” rating by Jefferies on Friday, October 23. The stock of Ignyta, Inc. (NASDAQ:RXDX) earned “Outperform” rating by Credit Suisse on Thursday, January 21. Piper Jaffray maintained Ignyta, Inc. (NASDAQ:RXDX) on Wednesday, August 12 with “Overweight” rating. The rating was maintained by Credit Suisse on Tuesday, March 15 with “Outperform”. JP Morgan maintained the stock with “Overweight” rating in Thursday, October 12 report. On Monday, July 10 the stock rating was maintained by Cantor Fitzgerald with “Buy”.

Another recent and important Ignyta, Inc. (NASDAQ:RXDX) news was published by Businesswire.com which published an article titled: “Ignyta to Participate at the Global Mizuho Investor Conference” on November 29, 2017.

Armistice Capital Llc, which manages about $784.66M US Long portfolio, upped its stake in Vanda Pharmaceuticals Inc (NASDAQ:VNDA) by 456,000 shares to 2.06 million shares, valued at $33.64M in 2017Q2, according to the filing. It also increased its holding in Bluebird Bio Inc (NASDAQ:BLUE) by 4,000 shares in the quarter, for a total of 28,000 shares, and has risen its stake in Deckers Outdoor Corp (Call) (NYSE:DECK).

Another recent and important John Bean Technologies Corporation (NYSE:JBT) news was published by Nasdaq.com which published an article titled: “John Bean Technologies Corporation (JBT) Ex-Dividend Date Scheduled for August …” on August 16, 2017.

Champlain Investment Partners Llc, which manages about $6.04 billion and $8.18B US Long portfolio, decreased its stake in Qualys Inc. (NASDAQ:QLYS) by 172,121 shares to 2.13M shares, valued at $86.98M in 2017Q2, according to the filing. It also reduced its holding in W.W. Grainger Inc. (NYSE:GWW) by 68,495 shares in the quarter, leaving it with 364,100 shares, and cut its stake in Ansys Inc. (NASDAQ:ANSS).

Investors sentiment increased to 1.87 in Q2 2017. Its up 0.65, from 1.22 in 2017Q1. It improved, as 24 investors sold JBT shares while 47 reduced holdings. 36 funds opened positions while 97 raised stakes. 31.08 million shares or 2.14% more from 30.43 million shares in 2017Q1 were reported. Cortina Asset Management Lc invested in 0.81% or 195,075 shares. Barclays Public Limited Com invested in 3,758 shares. New York-based Amalgamated Comml Bank has invested 0.01% in John Bean Technologies Corporation (NYSE:JBT). Hanseatic Management Services Incorporated accumulated 50 shares or 0% of the stock. Assetmark holds 320 shares or 0% of its portfolio. Bnp Paribas Arbitrage reported 11,291 shares or 0% of all its holdings. Teacher Retirement Sys Of Texas holds 2,496 shares or 0% of its portfolio. Oak Ridge Invs Ltd holds 0.23% or 74,472 shares. 274,311 are held by Epoch Partners Incorporated. Sg Americas Securities Ltd holds 0% of its portfolio in John Bean Technologies Corporation (NYSE:JBT) for 4,765 shares. Massmutual Fsb Adv reported 3,081 shares or 0% of all its holdings. Moreover, Pinebridge Invests Limited Partnership has 0.01% invested in John Bean Technologies Corporation (NYSE:JBT). Cramer Rosenthal Mcglynn Limited Co stated it has 0.24% in John Bean Technologies Corporation (NYSE:JBT). Waddell Reed Financial Inc accumulated 486,230 shares. Panagora Asset Management reported 0% in John Bean Technologies Corporation (NYSE:JBT).

Among 9 analysts covering John Bean Technologies Corporation (NYSE:JBT), 7 have Buy rating, 0 Sell and 2 Hold. Therefore 78% are positive. John Bean Technologies Corporation has $115 highest and $75 lowest target. $95.67’s average target is -16.92% below currents $115.15 stock price. John Bean Technologies Corporation had 13 analyst reports since April 19, 2016 according to SRatingsIntel. The company was initiated on Friday, June 2 by J.P. Morgan. On Friday, June 17 the stock rating was initiated by BB&T Capital with “Buy”. The stock has “Buy” rating by Sidoti on Tuesday, February 28. CL King upgraded John Bean Technologies Corporation (NYSE:JBT) rating on Wednesday, April 12. CL King has “Buy” rating and $103 target. The rating was maintained by Robert W. Baird with “Buy” on Thursday, August 24. The rating was initiated by William Blair on Tuesday, April 19 with “Outperform”. BMO Capital Markets maintained John Bean Technologies Corporation (NYSE:JBT) rating on Tuesday, April 11. BMO Capital Markets has “Outperform” rating and $105 target. The rating was maintained by Robert W. Baird on Friday, October 13 with “Buy”. The firm has “Outperform” rating by Robert W. Baird given on Wednesday, October 25. The stock of John Bean Technologies Corporation (NYSE:JBT) earned “Neutral” rating by Sidoti on Friday, December 2.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: